Signature Estate & Investment Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,061
| Closed | -$2.36M | – | 186 |
|
|
2023
Q3 | $2.36M | Buy |
12,061
+465
| +4% | +$91.1K | 0.08% | 74 |
|
|
2023
Q2 | $2.44M | Buy |
11,596
+819
| +8% | +$172K | 0.08% | 70 |
|
|
2023
Q1 | $2.18M | Buy |
10,777
+902
| +9% | +$182K | 0.08% | 76 |
|
|
2022
Q4 | $2.15M | Buy |
9,875
+379
| +4% | +$82.6K | 0.08% | 79 |
|
|
2022
Q3 | $1.87M | Buy |
9,496
+964
| +11% | +$190K | 0.09% | 71 |
|
|
2022
Q2 | $1.83M | Buy |
8,532
+1,853
| +28% | +$396K | 0.09% | 70 |
|
|
2022
Q1 | $1.9M | Buy |
6,679
+814
| +14% | +$231K | 0.09% | 69 |
|
|
2021
Q4 | $2.21M | Buy |
5,865
+548
| +10% | +$206K | 0.1% | 69 |
|
|
2021
Q3 | $2.19M | Sell |
5,317
-570
| -10% | -$235K | 0.11% | 62 |
|
|
2021
Q2 | $2.18M | Sell |
5,887
-933
| -14% | -$345K | 0.1% | 60 |
|
|
2021
Q1 | $1.98M | Buy |
6,820
+255
| +4% | +$73.9K | 0.1% | 67 |
|
|
2020
Q4 | $1.64M | Sell |
6,565
-93
| -1% | -$23.2K | 0.09% | 73 |
|
|
2020
Q3 | $1.51M | Sell |
6,658
-643
| -9% | -$146K | 0.09% | 66 |
|
|
2020
Q2 | $1.27M | Sell |
7,301
-810
| -10% | -$141K | 0.09% | 74 |
|
|
2020
Q1 | $1.02M | Buy |
+8,111
| New | +$1.02M | 0.08% | 85 |
|